Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Depression (3)
- Anhedonia (2)
- Anxiety (2)
- Cancer (2)
- Prostate (2)
-
- Prostate cancer (2)
- Adult (1)
- Aged (1)
- Androgen deprivation therapy (1)
- Arousal (1)
- Arthralgia (1)
- Article (1)
- Bone pain (1)
- Cancer hormone therapy (1)
- Cancer radiotherapy (1)
- Comorbidity (1)
- Confusion (1)
- Coping (1)
- Cravings (1)
- EFT (1)
- Emotional Freedom Techniques (1)
- Energy (1)
- Fatigue (1)
- Fear (1)
- Food (1)
- Hormone (1)
- Hormone therapy (1)
- Human (1)
- Libido disorder (1)
- Major clinical study (1)
- Publication
Articles 1 - 5 of 5
Full-Text Articles in Arts and Humanities
Clinical Benefits Of Emotional Freedom Techniques On Food Cravings At 12-Months Follow-Up: A Randomized Controlled Trial, Peta Stapleton, Teri Sheldon, Brett Porter
Clinical Benefits Of Emotional Freedom Techniques On Food Cravings At 12-Months Follow-Up: A Randomized Controlled Trial, Peta Stapleton, Teri Sheldon, Brett Porter
Peta B. Stapleton
This randomized, single-blind, crossover trial tested whether participants who used Emotional Freedom Techniques (EFT) maintained reduced food cravings after 12-months and updates previously reported 6 month findings. Ninety-six overweight/obese adults were allocated to a 4-week EFT treatment or wait list condition. Degree of food craving, perceived power of food, restraint capabilities, and psychological symptoms were assessed pre- and post-test and at 12-month follow-up for collapsed groups. Significant improvements occurred in weight, body mass index, food cravings, subjective power of food, craving restraint, and psychological coping for EFT participants from pre-test to 12 months (p < .05). It appears EFT can result in participants maintaining reduced cravings over time and affect weight and BMI in overweight and obese individuals.
Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety And Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications For Psychosocial Therapy Interventions, Christopher Sharpley, Vicki Bitsika, David Christie
Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety And Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications For Psychosocial Therapy Interventions, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Antiandrogen therapy (AAT) is a common adjunct treatment for prostate cancer (PCa) patients and has shown significant benefits to long-term outcomes from radiation or surgery. Although AAT has some adverse side effects and data from breast cancer patients indicate that such side effects from hormonal therapies may contribute to anxiety and depression and may also hinder AAT treatment compliance, this issue has not been investigated within a sample of PCa patients. This study explores the incidence of AAT side effects in a sample of PCa patients, the links between those side effects and anxiety and depression, the possible ways in …
Do Prostate Cancer Patients Suffer More From Depressed Mood Or Anhedonia?, Christopher Sharpley, Vicki Bitsika, David Christie
Do Prostate Cancer Patients Suffer More From Depressed Mood Or Anhedonia?, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Objective: This study aimed to compare the prevalence of depressed mood and anhedonia in a sample of men with prostate cancer (PCa) and to determine which of these key symptoms contributed most to the overall depressive status of that sample. Method: From Zung Self-rating Depression Scale (SDS) responses collected on 526 PCa patients, direct comparisons were made between the prevalence of the first two DSM-IV-TR symptoms of Major Depressive Episode. These symptoms were then tested for their predictive power on depression total score and Zung’s criteria for ‘clinically significant’ depression. Results: Mean scores for anhedonia were significantly higher than for …
How Prostate Cancer Patients Cope: Evaluation And Refinement Of The Prostate Cancer Patients' Coping Strategies Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
How Prostate Cancer Patients Cope: Evaluation And Refinement Of The Prostate Cancer Patients' Coping Strategies Questionnaire, Christopher Sharpley, Vicki Bitsika, David Christie
Vicki Bitsika
Background: Prostate cancer (PCa) patients suffer from identifiable stressors that may cause them anxiety and/or depression. In a previous study, an initial exploration of the ways in which PCa patients seek to cope with those stressors was described. However, several methodological limitations prevented direct comparisons of the relative effectiveness of patients’ coping strategies. To further investigate this issue, a standardised format was used to present the most commonly-used coping strategies to a new sample of PCa patients and to compare the effectiveness of those strategies. Methods: A total of 147 PCa patients completed a background questionnaire and the Prostate Cancer …
Comorbidity Of Anxiety-Depression Among Australian University Students: Implications For Student Counsellors, Vicki Bitsika, Christopher Sharpley
Comorbidity Of Anxiety-Depression Among Australian University Students: Implications For Student Counsellors, Vicki Bitsika, Christopher Sharpley
Vicki Bitsika
The incidence, factor structure and scale item differences in anxiety-depression comorbidity were investigated in a sample of Australian university students defined according to the presence of anxiety and/or depression. The incidence of anxiety-depression comorbidity was over 32%, about four times that for anxiety or depression alone. Participants with comorbidity had significantly higher Selfrating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS) total and factor scores than those with anxiety or depression alone. The major differences between the comorbid and unitary disordered subgroups were for self-disintegration and autonomic arousal. Comorbidity of anxiety and depression is a more serious disorder than either …